Scientists have developed special gallium-based liquid metal microrobots capable of navigating freely through human blood vessels to deliver targeted medications directly to tumor sites.
This cutting-edge technology allows treatments to focus strictly on affected areas, significantly reducing side effects during therapy.
This breakthrough in medical technology could radically transform approaches to oncological treatment, addressing one of cancer therapy's main challenges: damage to healthy tissue. Targeted drug delivery increases treatment efficacy while easing side effects for patients.
Although the technology shows immense promise, further clinical trials and widespread adoption will still take time.
